# Ebay Inc: financial statements, quarterly

EBAY · Nasdaq · CIK 1065088 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ebay.md) · [Financials](/companies/ebay/financials.md) · [Filings](/companies/ebay/filings.md) · [Insiders](/companies/ebay/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ebay/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,562 d](/filings/0001065088-26-000027.md) | [2,556](/filings/0001065088-25-000064.md) | [2,572](/filings/0001065088-25-000077.md) | [2,576](/filings/0001065088-25-000127.md) | [2,579 d](/filings/0001065088-26-000027.md) | [2,585](/filings/0001065088-26-000093.md) | [2,730](/filings/0001065088-26-000177.md) | [2,820](/filings/0001065088-26-000212.md) | [2,965 d](/filings/0001065088-26-000027.md) | [3,089](/filings/0001065088-26-000093.md) | [3,134](/filings/0001065088-26-000177.md) | [3,206](/filings/0001065088-26-000212.md) |
| Cost of revenue | $m | [710 d](/filings/0001065088-26-000027.md) | [700](/filings/0001065088-25-000064.md) | [735](/filings/0001065088-25-000077.md) | [727](/filings/0001065088-25-000127.md) | [718 d](/filings/0001065088-26-000027.md) | [697](/filings/0001065088-26-000093.md) | [750](/filings/0001065088-26-000177.md) | [794](/filings/0001065088-26-000212.md) | [928 d](/filings/0001065088-26-000027.md) | [802](/filings/0001065088-26-000093.md) | [832](/filings/0001065088-26-000177.md) | [887](/filings/0001065088-26-000212.md) |
| Gross profit | $m | [1,852 d](/filings/0001065088-26-000027.md) | [1,856](/filings/0001065088-25-000064.md) | [1,837](/filings/0001065088-25-000077.md) | [1,849](/filings/0001065088-25-000127.md) | [1,861 d](/filings/0001065088-26-000027.md) | [1,888](/filings/0001065088-26-000093.md) | [1,980](/filings/0001065088-26-000177.md) | [2,026](/filings/0001065088-26-000212.md) | [2,037 d](/filings/0001065088-26-000027.md) | [2,287](/filings/0001065088-26-000093.md) | [2,302](/filings/0001065088-26-000177.md) | [2,319](/filings/0001065088-26-000212.md) |
| Research and development | $m | [399 d](/filings/0001065088-26-000027.md) | [351](/filings/0001065088-25-000064.md) | [379](/filings/0001065088-25-000077.md) | [374](/filings/0001065088-25-000127.md) | [375 d](/filings/0001065088-26-000027.md) | [393](/filings/0001065088-26-000093.md) | [452](/filings/0001065088-26-000177.md) | [455](/filings/0001065088-26-000212.md) | [342 d](/filings/0001065088-26-000027.md) | [450](/filings/0001065088-26-000093.md) | [484](/filings/0001065088-26-000177.md) | [517](/filings/0001065088-26-000212.md) |
| Operating income | $m | [410 d](/filings/0001065088-26-000027.md) | [631](/filings/0001065088-25-000064.md) | [549](/filings/0001065088-25-000077.md) | [595](/filings/0001065088-25-000127.md) | [543 d](/filings/0001065088-26-000027.md) | [611](/filings/0001065088-26-000093.md) | [479](/filings/0001065088-26-000177.md) | [571](/filings/0001065088-26-000212.md) | [616 d](/filings/0001065088-26-000027.md) | [611](/filings/0001065088-26-000093.md) | [676](/filings/0001065088-26-000177.md) | [616](/filings/0001065088-26-000212.md) |
| Interest expense | $m | [65.0 d](/filings/0001065088-24-000036.md) | [66.0](/filings/0001065088-24-000076.md) | [65.0](/filings/0001065088-25-000077.md) | [63.0](/filings/0001065088-25-000127.md) | [65.0 d](/filings/0001065088-26-000027.md) | [61.0](/filings/0001065088-26-000093.md) | [62.0](/filings/0001065088-26-000177.md) | [62.0](/filings/0001065088-26-000212.md) | [61.0 d](/filings/0001065088-26-000027.md) | [61.0](/filings/0001065088-26-000093.md) | [65.0](/filings/0001065088-26-000177.md) | [64.0](/filings/0001065088-26-000212.md) |
| Income tax | $m | [303 d](/filings/0001065088-26-000027.md) | [97.0](/filings/0001065088-25-000064.md) | [102](/filings/0001065088-25-000077.md) | [161](/filings/0001065088-25-000127.md) | [(63.0) d](/filings/0001065088-26-000027.md) | [128](/filings/0001065088-26-000093.md) | [107](/filings/0001065088-26-000177.md) | [(25.0)](/filings/0001065088-26-000212.md) | [101 d](/filings/0001065088-26-000027.md) | [106](/filings/0001065088-26-000093.md) | [113](/filings/0001065088-26-000177.md) | [104](/filings/0001065088-26-000212.md) |
| Net income | $m | [724 d](/filings/0001065088-26-000027.md) | [438](/filings/0001065088-25-000064.md) | [224](/filings/0001065088-25-000077.md) | [634](/filings/0001065088-25-000127.md) | [679 d](/filings/0001065088-26-000027.md) | [499](/filings/0001065088-26-000093.md) | [364](/filings/0001065088-26-000177.md) | [628](/filings/0001065088-26-000212.md) | [540 d](/filings/0001065088-26-000027.md) | [512](/filings/0001065088-26-000093.md) | [550](/filings/0001065088-26-000177.md) | [497](/filings/0001065088-26-000212.md) |
| Diluted EPS | $ per share | not reported | [0.85](/filings/0001065088-25-000064.md) | [0.45](/filings/0001065088-25-000077.md) | [1.29](/filings/0001065088-25-000127.md) | not reported | [1.05](/filings/0001065088-26-000093.md) | [0.78](/filings/0001065088-26-000177.md) | [1.34](/filings/0001065088-26-000212.md) | not reported | [1.12](/filings/0001065088-26-000093.md) | [1.21](/filings/0001065088-26-000177.md) | [1.10](/filings/0001065088-26-000212.md) |
| Basic EPS | $ per share | not reported | [0.85](/filings/0001065088-25-000064.md) | [0.45](/filings/0001065088-25-000077.md) | [1.31](/filings/0001065088-25-000127.md) | not reported | [1.07](/filings/0001065088-26-000093.md) | [0.79](/filings/0001065088-26-000177.md) | [1.38](/filings/0001065088-26-000212.md) | not reported | [1.14](/filings/0001065088-26-000093.md) | [1.24](/filings/0001065088-26-000177.md) | [1.12](/filings/0001065088-26-000212.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.0](/filings/0001065088-26-000027.md) | [2.1](/filings/0001065088-25-000064.md) | [2.0](/filings/0001065088-25-000077.md) | [1.6](/filings/0001065088-25-000127.md) | [2.4](/filings/0001065088-26-000027.md) | [3.0](/filings/0001065088-26-000093.md) | [2.1](/filings/0001065088-26-000177.md) | [2.4](/filings/0001065088-26-000212.md) | [1.9](/filings/0001065088-26-000212.md) | [2.9](/filings/0001065088-26-000093.md) | [2.3](/filings/0001065088-26-000177.md) | [1.2](/filings/0001065088-26-000212.md) |
| Current assets | $bn | [11.0](/filings/0001065088-25-000037.md) | [10.4](/filings/0001065088-24-000076.md) | [7.3](/filings/0001065088-24-000145.md) | [7.1](/filings/0001065088-24-000199.md) | [7.6](/filings/0001065088-26-000027.md) | [6.9](/filings/0001065088-25-000064.md) | [5.9](/filings/0001065088-25-000077.md) | [5.4](/filings/0001065088-25-000127.md) | [5.1](/filings/0001065088-26-000212.md) | [6.3](/filings/0001065088-26-000093.md) | [6.0](/filings/0001065088-26-000177.md) | [4.8](/filings/0001065088-26-000212.md) |
| Total assets | $bn | [21.6](/filings/0001065088-25-000037.md) | [21.4](/filings/0001065088-24-000076.md) | [20.4](/filings/0001065088-24-000145.md) | [19.9](/filings/0001065088-24-000199.md) | [19.4](/filings/0001065088-26-000027.md) | [19.0](/filings/0001065088-25-000064.md) | [18.0](/filings/0001065088-25-000077.md) | [17.8](/filings/0001065088-25-000127.md) | [17.4](/filings/0001065088-26-000212.md) | [17.9](/filings/0001065088-26-000093.md) | [17.9](/filings/0001065088-26-000177.md) | [18.0](/filings/0001065088-26-000212.md) |
| Current liabilities | $bn | [4.5](/filings/0001065088-25-000037.md) | [5.2](/filings/0001065088-24-000076.md) | [5.8](/filings/0001065088-24-000145.md) | [5.6](/filings/0001065088-24-000199.md) | [6.1](/filings/0001065088-26-000027.md) | [5.9](/filings/0001065088-25-000064.md) | [5.9](/filings/0001065088-25-000077.md) | [5.8](/filings/0001065088-25-000127.md) | [4.6](/filings/0001065088-26-000212.md) | [5.1](/filings/0001065088-26-000093.md) | [5.9](/filings/0001065088-26-000177.md) | [6.1](/filings/0001065088-26-000212.md) |
| Total liabilities | $bn | [15.2](/filings/0001065088-25-000037.md) | [15.1](/filings/0001065088-24-000076.md) | [14.9](/filings/0001065088-24-000145.md) | [14.5](/filings/0001065088-24-000199.md) | [14.2](/filings/0001065088-26-000027.md) | [14.0](/filings/0001065088-25-000064.md) | [13.2](/filings/0001065088-25-000077.md) | [13.1](/filings/0001065088-25-000127.md) | [13.0](/filings/0001065088-26-000212.md) | [13.5](/filings/0001065088-26-000093.md) | [13.3](/filings/0001065088-26-000177.md) | [13.6](/filings/0001065088-26-000212.md) |
| Long-term debt | $bn | [7.0](/filings/0001065088-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.8](/filings/0001065088-25-000037.md) | [1.6](/filings/0001065088-24-000076.md) | [1.6](/filings/0001065088-24-000145.md) | [0.8](/filings/0001065088-24-000199.md) | [1.2](/filings/0001065088-26-000027.md) | [0.4](/filings/0001065088-25-000064.md) | [1.2](/filings/0001065088-25-000077.md) | [1.2](/filings/0001065088-25-000127.md) | [0.8](/filings/0001065088-26-000212.md) | [0.8](/filings/0001065088-26-000093.md) | [0.9](/filings/0001065088-26-000177.md) | [0.9](/filings/0001065088-26-000212.md) |
| Short-term borrowings | $bn | [0.8](/filings/0001065088-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.4](/filings/0001065088-26-000027.md) | [6.3](/filings/0001065088-25-000064.md) | [5.5](/filings/0001065088-25-000077.md) | [5.4](/filings/0001065088-25-000127.md) | [5.2](/filings/0001065088-26-000027.md) | [4.8](/filings/0001065088-26-000093.md) | [4.6](/filings/0001065088-26-000177.md) | [4.6](/filings/0001065088-26-000212.md) | [4.5](/filings/0001065088-26-000212.md) | [4.4](/filings/0001065088-26-000093.md) | [4.7](/filings/0001065088-26-000177.md) | [4.4](/filings/0001065088-26-000212.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0001065088-26-000027.md) | [615](/filings/0001065088-24-000076.md) | [367 d](/filings/0001065088-24-000145.md) | [755 d](/filings/0001065088-25-000127.md) | [677 d](/filings/0001065088-26-000027.md) | [755](/filings/0001065088-26-000093.md) | [(340) d](/filings/0001065088-26-000177.md) | [862 d](/filings/0001065088-26-000212.md) | [682 d](/filings/0001065088-26-000027.md) | [969](/filings/0001065088-26-000093.md) | [523 d](/filings/0001065088-26-000177.md) | [875 d](/filings/0001065088-26-000212.md) |
| Capital expenditure | $m | [126 d](/filings/0001065088-26-000027.md) | [143](/filings/0001065088-25-000064.md) | [89.0 d](/filings/0001065088-25-000077.md) | [109 d](/filings/0001065088-25-000127.md) | [117 d](/filings/0001065088-26-000027.md) | [111](/filings/0001065088-26-000093.md) | [101 d](/filings/0001065088-26-000177.md) | [97.0 d](/filings/0001065088-26-000212.md) | [216 d](/filings/0001065088-26-000027.md) | [72.0](/filings/0001065088-26-000093.md) | [223 d](/filings/0001065088-26-000177.md) | [126 d](/filings/0001065088-26-000212.md) |
| Dividends paid | $m | [129 d](/filings/0001065088-26-000027.md) | [139](/filings/0001065088-25-000064.md) | [135](/filings/0001065088-25-000077.md) | [131](/filings/0001065088-25-000127.md) | [128 d](/filings/0001065088-26-000027.md) | [134](/filings/0001065088-26-000093.md) | [134](/filings/0001065088-26-000177.md) | [132](/filings/0001065088-26-000212.md) | [131 d](/filings/0001065088-26-000027.md) | [139](/filings/0001065088-26-000093.md) | [138](/filings/0001065088-26-000177.md) | [138](/filings/0001065088-26-000212.md) |
| Share repurchases | $m | [283 d](/filings/0001065088-26-000027.md) | [453](/filings/0001065088-25-000064.md) | [1,030 d](/filings/0001065088-25-000077.md) | [755 d](/filings/0001065088-25-000127.md) | [911 d](/filings/0001065088-26-000027.md) | [615](/filings/0001065088-26-000093.md) | [624 d](/filings/0001065088-26-000177.md) | [626 d](/filings/0001065088-26-000212.md) | [635 d](/filings/0001065088-26-000027.md) | [486](/filings/0001065088-26-000093.md) | [323 d](/filings/0001065088-26-000177.md) | [664 d](/filings/0001065088-26-000212.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [541](/filings/0001065088-24-000076.md) | [537](/filings/0001065088-24-000145.md) | [532](/filings/0001065088-24-000199.md) | [519](/filings/0001065088-25-000064.md) | [507](/filings/0001065088-25-000077.md) | [494](/filings/0001065088-25-000127.md) | [475](/filings/0001065088-26-000093.md) | [470](/filings/0001065088-26-000177.md) | [467](/filings/0001065088-26-000212.md) | [457](/filings/0001065088-26-000093.md) | [455](/filings/0001065088-26-000177.md) | [453](/filings/0001065088-26-000212.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 439,000,000 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001065088-26-000212.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:14 ET. No prices; not investment advice.